Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Patient Compliance × potassium oxonate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3 Patient Compliance 1 Pancreatic Neoplasms 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

potassium oxonate 1 Radiation 1 Oxaliplatin 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03448549 2020-03-06

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Peking University Cancer Hospital & Institute

Phase 3 Unknown

Gastrointestinal

Patient Compliance, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡